Clinical Trial Start-Up Guide in Asia-Pacific: Regulatory Timelines, Ethics Approval (EC) Processes & IMP Import Requirements
Key takeaways Asia-Pacific (APAC) has become one of the most attractive regions for clinical trials due to patient diversity, strong investigator networks, and lower operational costs. However, clinical trial start-up timelines remain highly fragmented across countries. Singapore remains the fastest and most predictable market for clinical trial activation due to centralized systems, parallel submissions, and […]
Read More →